Contents

Current Alzheimer Research, Volume 6 - Number 2

Editorial [Hot Topic:Advances in Alzheimer Therapy: Understanding Pharmacological Approaches to the Disease (Guest Editors: Ana Martinez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig)]

, 6(2): 83 - 85

Ana Martinez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig


DOI: 10.2174/156720509787602924




Cholinesterase Inhibitors and Beyond

, 6(2): 86 - 96

Giancarlo Pepeu and Maria Grazia Giovannini


DOI: 10.2174/156720509787602861




Responders to ChEI Treatment of Alzheimers Disease Show Restitution of Normal Regional Cortical Activation

, 6(2): 97 - 111

Annalena Venneri, William J. McGeown and Michael F. Shanks


DOI: 10.2174/156720509787602933




M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimers Disease

, 6(2): 112 - 117

Antonella Caccamo, Abraham Fisher and Frank M. LaFerla


DOI: 10.2174/156720509787602915




GEPT Extract Reduces Aβ Deposition by Regulating the Balance Between Production and Degradation of Aβ in APPV717I Transgenic Mice

, 6(2): 118 - 131

Jinzhou Tian, Jing Shi, Leiming Zhang, Junxiang Yin, Quan Hu, Yi Xu, Shuli Sheng, Pengwen Wang, Ying Ren, Rong Wang and Yongyan Wang


DOI: 10.2174/156720509787602942




Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form

, 6(2): 132 - 136

Kazuhiro Ito, Ken-Ichi Ishibashi, Takami Tomiyama, Tomohiro Umeda, Kei-Ichi Yamamoto, Erika Kitajima, Toshiki Idomoto, Toshie Nagatomo and Hiroshi Mori


DOI: 10.2174/156720509787602889




Visualization of Brain Amyloid and Microglial Activation in Mouse Models of Alzheimers Disease

, 6(2): 137 - 143

Makoto Higuchi


DOI: 10.2174/156720509787602906




Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders

, 6(2): 144 - 151

Bruno Vellas, R. Black, Leon J. Thal, Nick C. Fox, M. Daniels, G. McLennan, C. Tompkins, C. Leibman, M. Pomfret and Michael Grundman


DOI: 10.2174/156720509787602852




Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease

, 6(2): 152 - 157

Karim Belarbi, Katharina Schindowski, Sylvie Burnouf, Raphaelle Caillierez, Marie-Eve Grosjean, Dominique Demeyer, Malika Hamdane, Nicolas Sergeant, David Blum and Luc Buee


DOI: 10.2174/156720509787602843




Development of a Non Invasive NGF-Based Therapy for Alzheimers Disease

, 6(2): 158 - 170

Sonia Covaceuszach, Simona Capsoni, Gatsuella Ugolini, F. Spirito, D. Vignone and Antonio Cattaneo


DOI: 10.2174/156720509787602870




Natural Non-Trasgenic Animal Models for Research in Alzheimers Disease

, 6(2): 171 - 178

Manuel Sarasa and Pedro Pesini


DOI: 10.2174/156720509787602834




Structural and Functional MRI in Mild Cognitive Impairment

, 6(2): 179 - 185

Maija Pihlajamaki, Anne M. Jauhiainen and Hilkka Soininen


DOI: 10.2174/156720509787602898




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science